Production and Verification of Anti-Tumor Activity of Monoclonal Anti-EGFR-Recombinant PE38 Immunotoxin in A431 Tumor Cells
ImmunoAnalysis · 2021
DOI: 10.34172/ia.2021.03 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoAnalysis, 2021. Verfasst von Khalil Hajiasgharzadeh und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Background
Tumor growth and progression depend largely on the activity of cell membrane receptors like epidermal growth factor receptor (EGFR). This receptor plays a significant role in the growth and survival of many solid tumors. Its biological feature makes it a highly appealing target for cancer treatment. On the other hand, immunotherapy is an efficient approach in cancer treatment, and immunotoxins have a predominant position herein. Thus, this approach can be used in high EGFR-expressed cancer therapy.
Methods
In this study, the production of monoclonal anti-EGFR-recombinant PE38 was used as the special treatment against EGFR-activated cancers. For this purpose, the A431 cell line originating from a squamous carcinoma was used. In order the production of this immunotoxin, the toxin was conjugated with an antibody by chemical method. To confirm conjugation and its purity, SDS-PAGE was performed by immunotoxin electrophoresis. Then, the antitumor effects of immunotoxin in the induction of apoptosis of tumoral cells were assessed by the ELISA method.
Results
The conjugation and purity of immunotoxin were confirmed by immunotoxin electrophoresis. Also, the ELISA results indicate that the produced immunotoxin induced 62% antigen-specific apoptosis (P
Zitieren
APA
Hajiasgharzadeh, K., Maleki, L. A., & Baradaran, B. (2021). Production and Verification of Anti-Tumor Activity of Monoclonal Anti-EGFR-Recombinant PE38 Immunotoxin in A431 Tumor Cells. ImmunoAnalysis. https://doi.org/10.34172/ia.2021.03
Vancouver
Hajiasgharzadeh K, Maleki LA, Baradaran B. Production and Verification of Anti-Tumor Activity of Monoclonal Anti-EGFR-Recombinant PE38 Immunotoxin in A431 Tumor Cells. ImmunoAnalysis. 2021. doi:10.34172/ia.2021.03
BibTeX
@article{Hajiasgharzadeh2021,
author = {Hajiasgharzadeh, Khalil and Maleki, Leili Aghebati and Baradaran, Behzad},
title = {Production and Verification of Anti-Tumor Activity of Monoclonal Anti-EGFR-Recombinant PE38 Immunotoxin in A431 Tumor Cells},
journal = {ImmunoAnalysis},
year = {2021},
doi = {10.34172/ia.2021.03}
}
EUVIMED